Position in BIOA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$638,489
New position
Shares Held
36,506
first reported quarter
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VOLORIDGE INVESTMENT MANAGEMENT, LLC holds $160,704,963 across 12 Drug Manufacturers - Specialty & Generic names. BIOA ranks #11 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
853,063 | $100,840,577 | |
| 2 | HLN |
Haleon plc
|
1,667,494 | $16,691,614 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
379,586 | $11,433,130 | |
| 4 | VTRS |
Viatris Inc
|
492,473 | $6,653,310 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
200,306 | $6,624,119 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
134,516 | $6,476,945 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
171,188 | $3,353,572 | |
| 8 | LQDA |
Liquidia Corp
|
75,602 | $2,853,219 |
All Filings in BIOA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $638,489 | 36,506 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||